Clinical trial
Monitoring Circulating Tumor DNA After Chemotherapy in Elderly Patients With Acute Leukemia
NCT04157569 is registered in ClinicalTrials.gov with Navy General Hospital, Beijing as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Monitoring Circulating Tumor DNA After Chemotherapy in Elderly Patients With Acute Leukemia
- Lead sponsor
- Navy General Hospital, Beijing
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- November 5, 2019
- Completion date
- December 31, 2029
- Enrollment
- 200 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
acute leukemia